Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year debt growth rate
3Y CAGR
+145.9%/yr
Quarterly compound
Percentile
P79
Within normal range
vs 3Y Ago
14.9x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.30% |
| Q3 2025 | 179.47% |
| Q2 2025 | 3.49% |
| Q1 2025 | 0.17% |
| Q4 2024 | 0.36% |
| Q3 2024 | 0.91% |
| Q2 2024 | 0.29% |
| Q1 2024 | 0.45% |
| Q4 2023 | 0.54% |
| Q3 2023 | 16.96% |
| Q2 2023 | 17.78% |
| Q1 2023 | 69.61% |
| Q4 2022 | 0.15% |
| Q3 2022 | 0.17% |
| Q2 2022 | 7044.68% |
| Q1 2022 | -12.67% |
| Q4 2021 | -11.15% |
| Q3 2021 | -10.03% |
| Q2 2021 | 41.02% |
| Q1 2021 | -10.05% |
| Q4 2020 | -8.92% |
| Q3 2020 | 65.96% |
| Q2 2020 | -13.04% |
| Q1 2020 | -11.54% |
| Q4 2019 | -9.99% |
| Q3 2019 | -9.08% |
| Q2 2019 | -8.22% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | -100.00% |
| Q2 2016 | -98.63% |
| Q1 2016 | -49.85% |